Association of HLA matching and donor age with clinical outcomes of allogeneic HCT from unrelated donors (UDs). Schematic representation of the risk associated with different combinations of donor age (young, ≤35 years; old, >35 years) and HLA-DP matching status by T-cell epitope in 10 of 10 HLA-matched UDs1 or HLA class I matching status by PBM in 9 of 10 HLA-matched UDs.8 Lines and arrows indicate not significant difference compared with the reference (ref), or significantly (P < .05) higher (in red) or lower (in green) hazard ratio (HR) as depicted in the symbol legend. Matched, allele matched; NP, HLA-DP nonpermissive mismatched; P, HLA-DP permissive mismatched; PBM-m, HLA class I PBM matched; PBM-mm, HLA class I PBM mismatched. Figure created with BioRender.com.

Association of HLA matching and donor age with clinical outcomes of allogeneic HCT from unrelated donors (UDs). Schematic representation of the risk associated with different combinations of donor age (young, ≤35 years; old, >35 years) and HLA-DP matching status by T-cell epitope in 10 of 10 HLA-matched UDs1 or HLA class I matching status by PBM in 9 of 10 HLA-matched UDs.8 Lines and arrows indicate not significant difference compared with the reference (ref), or significantly (P < .05) higher (in red) or lower (in green) hazard ratio (HR) as depicted in the symbol legend. Matched, allele matched; NP, HLA-DP nonpermissive mismatched; P, HLA-DP permissive mismatched; PBM-m, HLA class I PBM matched; PBM-mm, HLA class I PBM mismatched. Figure created with BioRender.com.

Close Modal

or Create an Account

Close Modal
Close Modal